176 related articles for article (PubMed ID: 14532158)
1. Signal transduction networks in rheumatoid arthritis.
Hammaker D; Sweeney S; Firestein GS
Ann Rheum Dis; 2003 Nov; 62 Suppl 2(Suppl 2):ii86-9. PubMed ID: 14532158
[TBL] [Abstract][Full Text] [Related]
2. Intracellular signaling pathways as a target for the treatment of rheumatoid arthritis.
Kumar S; Blake SM; Emery JG
Curr Opin Pharmacol; 2001 Jun; 1(3):307-13. PubMed ID: 11712756
[TBL] [Abstract][Full Text] [Related]
3. Orchestrated modulation of rheumatoid arthritis via crosstalking intracellular signaling pathways.
Ibrahim SSA; Huttunen KM
Inflammopharmacology; 2021 Aug; 29(4):965-974. PubMed ID: 33740220
[TBL] [Abstract][Full Text] [Related]
4. Signal transduction pathways and transcription factors as therapeutic targets in inflammatory disease: towards innovative antirheumatic therapy.
Tas SW; Remans PH; Reedquist KA; Tak PP
Curr Pharm Des; 2005; 11(5):581-611. PubMed ID: 15720277
[TBL] [Abstract][Full Text] [Related]
5. Histamine H1 receptor antagonist blocks histamine-induced proinflammatory cytokine production through inhibition of Ca2+-dependent protein kinase C, Raf/MEK/ERK and IKK/I kappa B/NF-kappa B signal cascades.
Matsubara M; Tamura T; Ohmori K; Hasegawa K
Biochem Pharmacol; 2005 Feb; 69(3):433-49. PubMed ID: 15652235
[TBL] [Abstract][Full Text] [Related]
6. Mitogen activated protein kinase inhibitors: where are we now and where are we going?
Sweeney SE; Firestein GS
Ann Rheum Dis; 2006 Nov; 65 Suppl 3(Suppl 3):iii83-8. PubMed ID: 17038480
[TBL] [Abstract][Full Text] [Related]
7. MAPK phosphatases as novel targets for rheumatoid arthritis.
Ralph JA; Morand EF
Expert Opin Ther Targets; 2008 Jul; 12(7):795-808. PubMed ID: 18554149
[TBL] [Abstract][Full Text] [Related]
8. Emerging targets of biologic therapies for rheumatoid arthritis.
Tarner IH; Müller-Ladner U; Gay S
Nat Clin Pract Rheumatol; 2007 Jun; 3(6):336-45. PubMed ID: 17538565
[TBL] [Abstract][Full Text] [Related]
9. Signal transduction in rheumatoid arthritis.
Sweeney SE; Firestein GS
Curr Opin Rheumatol; 2004 May; 16(3):231-7. PubMed ID: 15103250
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of NF-kappaB signaling by fenofibrate, a peroxisome proliferator-activated receptor-alpha ligand, presents a therapeutic strategy for rheumatoid arthritis.
Okamoto H; Iwamoto T; Kotake S; Momohara S; Yamanaka H; Kamatani N
Clin Exp Rheumatol; 2005; 23(3):323-30. PubMed ID: 15971419
[TBL] [Abstract][Full Text] [Related]
11. MAPK signalling in rheumatoid joint destruction: can we unravel the puzzle?
Meyer LH; Pap T
Arthritis Res Ther; 2005; 7(5):177-8. PubMed ID: 16207342
[TBL] [Abstract][Full Text] [Related]
12. Small-molecule inhibitors of NF-kappaB for the treatment of inflammatory joint disease.
Roshak AK; Callahan JF; Blake SM
Curr Opin Pharmacol; 2002 Jun; 2(3):316-21. PubMed ID: 12020477
[TBL] [Abstract][Full Text] [Related]
13. Role of nuclear factor-kappa B and mitogen-activated protein kinase signaling pathways in IL-1 beta-mediated induction of alpha-PDGF receptor expression in rat pulmonary myofibroblasts.
Lindroos PM; Rice AB; Wang YZ; Bonner JC
J Immunol; 1998 Oct; 161(7):3464-8. PubMed ID: 9759865
[TBL] [Abstract][Full Text] [Related]
14. Kinase inhibitors: the next generation of therapies in the treatment of rheumatoid arthritis.
MacFarlane LA; Todd DJ
Int J Rheum Dis; 2014 May; 17(4):359-68. PubMed ID: 24460872
[TBL] [Abstract][Full Text] [Related]
15. Signal transduction pathways: new targets for treating rheumatoid arthritis.
Morel J; Berenbaum F
Joint Bone Spine; 2004 Nov; 71(6):503-10. PubMed ID: 15589430
[TBL] [Abstract][Full Text] [Related]
16. Signal transduction in rheumatoid arthritis.
Piecyk M; Anderson P
Best Pract Res Clin Rheumatol; 2001 Dec; 15(5):789-803. PubMed ID: 11812022
[TBL] [Abstract][Full Text] [Related]
17. p38 pathway kinases as anti-inflammatory drug targets.
Schindler JF; Monahan JB; Smith WG
J Dent Res; 2007 Sep; 86(9):800-11. PubMed ID: 17720847
[TBL] [Abstract][Full Text] [Related]
18. Involvement of RAGE, MAPK and NF-κB pathways in AGEs-induced MMP-9 activation in HaCaT keratinocytes.
Zhu P; Ren M; Yang C; Hu YX; Ran JM; Yan L
Exp Dermatol; 2012 Feb; 21(2):123-9. PubMed ID: 22229442
[TBL] [Abstract][Full Text] [Related]
19. NF-kappaB: Holy Grail for rheumatoid arthritis?
Firestein GS
Arthritis Rheum; 2004 Aug; 50(8):2381-6. PubMed ID: 15334448
[No Abstract] [Full Text] [Related]
20. Role of nuclear factor-kappaB in the immune system and bone.
Jimi E; Ghosh S
Immunol Rev; 2005 Dec; 208():80-7. PubMed ID: 16313342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
